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CytotoxicityThe crude ethanolic extract, hexane, dichloromethane, ethyl acetate and aqueous fractions of Buddleja saligna
leaves were investigated for antiplasmodial, alpha-glucosidase and acetylcholinesterase inhibitory and cytotox-
icity properties. Although the crude extract displayed some level of activity, the hexane fraction demonstrated
the best antiplasmodial (IC50=8.5 μg/ml), alpha-glucosidase inhibitory (IC50=260 μg/ml) and anticholinester-
ase (IC50 = 124.8 μg/ml) activities. The safety index values of the hexane fraction [antiplasmodial (0.2), alpha-
glucosidase inhibition (0.007) and anticholinesterase (0.01)] revealed that the fraction is cytotoxic. These
ﬁndings highlight the importance of reporting the SI values of biologically active samples together with their
biological activities. It remains to be determined whether the toxicity observed is caused by the compounds
responsible for the biological activities investigated or not.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
In South Africa, plants have always and still remain a vital source of
therapeutics for various illnesses such as malaria, diabetes and mental
disorders in traditional medicine. One such plant is Buddleja saligna
Willd (Loganiaceae), also known as “umceba” and “igqeba-elimhlophe”
in Zulu. It is a small to medium-sized evergreen tree (10 m) growing in
warm moist areas but usually 4–5 m at high elevation (Aubrey, 2002).
As members of the genus have many healing properties, this species is
widely used in traditional medicine. Traditionally, it is used as a purga-
tive, to treat coughs, colds, diabetes, tuberculosis, thrush and sores,
anasarca and chest pains (Hutchings et al., 1996; Anonymous, 2013).
An unspeciﬁed species of Buddleja is used by the Sotho people in
South Africa to treat early nervous and mental illness (Watt and
Breyer-Brandwijk, 1962).
A number of biological activities have been reported for B. saligna.
These include anti-mycobacterial (Bamuamba et al., 2008), antibacteri-
al, antioxidant (Adedapo et al., 2009), and antimutagenic (Verschaevealysis of variance; CHO, Chinese
oroquine-sensitive; SI, selective
ghts reserved.and van Staden, 2008) properties. In line with the traditional use of
B. saligna, we report here the antiplasmodial, alpha-glucosidase (antidi-
abetic), anticholinesterase and cytotoxicity properties of B. saligna crude
extract and its fractions.
2. Materials and methods
2.1. Plant collection
Leaves of B. salignawere collected in May, 2013 from the Botanical
Garden of the University of KwaZulu-Natal, Pietermaritzburg, South
Africa. After identiﬁcation by the Curator, a voucher specimen
(Chukwujekwu #7 NU) was deposited in the Herbarium of the Univer-
sity of KwaZulu-Natal, Pietermaritzburg. Plant material was dried at
50 °C, powdered and stored in paper containers at ambient temperature
for less than 24 h prior to extraction.
2.2. Extraction and fractionation
The leaf powders (14.2 g) were extracted using 80% ethanol
(300 ml) with sonication for 1 h and then left overnight with stirring.
The extract was ﬁltered through a Büchner funnel using Whatman no.
1 ﬁlter paper. The extraction and ﬁltration were subsequently repeated
three times with 300 ml 80% ethanol, and the solvent from the com-
bined extracts evaporated under reduced pressure at 30 °C. Liquid–
Table 1
In vitro antiplasmodial activity of B. saligna crude extract and different fractions against
chloroquine-sensitive (CQS) strain of P. falciparum (NF54) and hexane fraction cytotoxic-
ity evaluation using a Chinese Hamster Ovarian (CHO) cell line.
Sample NF54: IC50 (μg/ml) CHO: IC50 (μg/ml) SI
Crude extract 27.0 ± 3.9 ND ND
Hexane fraction 8.5 ± 1.6 1.7 ± 0.31 0.2
Dichloromethane fraction 13.3 ± 3.1 ND ND
Ethyl acetate fraction 73.1 ± 4.0 ND ND
Aqueous fraction N100 ± ND ND ND
Chloroquine 0.0058 ± 0.0004
Artesunate 0.0041 ± 0.0003
Emetine 0.035 ± 0.02
Selectivity index (SI) = IC50 CHO/IC50 NF54; ND = not determined.
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aqueous methanol (300 ml, 80% v/v) followed by sequential extraction
with hexane, dichloromethane, ethyl acetate and water as described
by Chukwujekwu et al. (2013). All four fractions and crude extract
were used in subsequent assays.
2.3. Antiplasmodial assay
Samples were tested for antiplasmodial activity in triplicate against
chloroquine-sensitive (CQS) strain of Plasmodium falciparum (NF54) as
described by Chukwujekwu et al. (2014). The reference drugs used
were chloroquine diphosphate (CQ) (Sigma) and artesunate (Sigma).
2.4. Anticholinesterase assay
The acetylcholinesterase (AChE) inhibitory property of the crude
extracts and fractionswas determined using a 96-well microplate color-
imetric method (Ellman et al., 1961) as detailed by Fawole et al. (2010).
Galanthaminewas used as a positive control. Each sample was tested in
triplicate. The rate of reaction was calculated for each sample and the
percentage inhibition was determined as follows:
AChE inhibition %ð Þ ¼ 1− sample reaction rate=blank reaction rateð Þ½ 
 100
2.5. Alpha-glucosidase inhibitory activity
Alpha-glucosidase inhibitory activity was determined as described
by Rengasamy et al. (2013). Acarbose was used as a positive control.
The negative control had the same volume of phosphate buffer in
place of the sample volume. Each determination was done in triplicate.
Percentage inhibition by each sample was calculated using the
equation:





where Acontrol and Asample are the absorbance values of the negative
control and sample, respectively.
2.6. Cytotoxicity assay
The cytotoxicity assay was performed as previously described by
Chukwujekwu et al. (2014). Only the hexane fraction was selected for
cytotoxicity testing as better biological activity was displayed by this
fraction when compared to the crude extract and other fractions.
2.7. Data analysis
For the determination of IC50, a non-linear regression analysis was
done using GraphPad Prism (version 4.03) software. Data were subject-
ed to analysis of variance (ANOVA) followed byDuncan'smultiple range
test (where appropriate) using SPSS (version 10.0) software in order to
determine any signiﬁcant difference between the mean values.
3. Results and discussion
Table 1 presents the antiplasmodial and cytotoxicity properties as
well as the selective index (SI) of B. saligna crude extract and its frac-
tions. With the exception of water and ethyl acetate fractions, there
was an improvement in antiplasmodial activity of the other fractions
over the crude extract. A two to three times better antiplasmodial activ-
ity was recorded with dichloromethane and hexane fractions, respec-
tively when compared to the crude extract. Considering the good
antiplasmodial activity displayed by the hexane fraction, it was tested
for cytotoxicity. The SI of the hexane fraction (Table 1) with regards toantiplasmodial activity shows that this fraction was toxic. Previous
studies have reported antiplasmodial activity in certain Buddleja
species with or without SI values. For example, a dichloromethane
extract of B. salviifolia exhibited moderate antiplasmodial activity
(IC50: 22 μg/ml) against a chloroquine-sensitive strain of P. falciparum
(3D7) with a high SI value (N9) (Jonville et al., 2011). Using a multi-
drug resistant strain of P. falciparum (K1), Debenedetti et al. (2002) ob-
served good antiplasmodial activity (IC50: 8.9 μg/ml) with Buddleja
globosa water extract but there was no information on the cytotoxicity
of the extract. The current study highlighted the need to incorporate
safety evaluations when determining the biological activity of plant
extracts.
In a previous investigation, a hexane fraction of B. salignawas report-
ed to possess antimycobacterial activity and oleanolic acid was identi-
ﬁed as the antimycobacterial compound (Bamuamba et al., 2008). This
compound had an IC50 value greater than 100 μg/ml with regards to
its cytotoxicity activity using CHO cells (Bamuamba et al., 2008).
Oleanolic acid was inactive against a multi-drug resistant strain of
P. falciparum (K1) (Suksamrarn et al., 2003) but moderately active
against a chloroquine-sensitive strain (3D7) (Steele et al., 1999;
Sairaﬁanpour et al., 2003). Since oleanolic acid is known to exert very
moderate antiplasmodial activity against a chloroquine-sensitive strain
of P. falciparum, it could be that the antiplasmodial activity of the hexane
fraction in this study was enhanced through a synergistic interaction of
oleanolic acid with other constituents of the fraction. However, the very
low SI (0.2) recorded for the fraction is not encouraging. The
antiplasmodial activity exhibited by the hexane fraction could be due
to toxicity of the fraction on the parasites.
The anticholinesterase, alpha-glucosidase inhibitory activities, and
SI values of B. saligna crude extract and its fractions are presented in
Table 2. A signiﬁcantly higher anticholinesterase activity (lower IC50
values) was observed with the crude extract, hexane and ethyl acetate
fractions when compared to dichloromethane and water fractions.
Although the hexane fraction displayed the highest activity, its very
lowSI value suggests that it is very toxicwith regards to anticholinester-
ase activity. According to Fan et al. (2008), a methanol leaf extract of
B. davidii exhibited anticholinesterase inhibitory activity from which
the acetylcholinesterase inhibitor linarin was isolated. In the current
study, it is not known at this stage which phytochemical(s) is/are re-
sponsible for the observed anticholinesterase activity. B. saligna has
never been reported to contain the phytochemical linarin. However,
being a related species to B. davidii, it maywell be that it contains linarin
whichmight be responsible for the observed activity. Hopefully, further
study of the potent fractions will clarify which phytochemical(s) are
responsible for the activity.
Alpha-glucosidase inhibitors are known to be very active in reducing
postprandial glucose by suppressing the absorption of glucose and are
effective in the treatment and management of diabetes and obesity
(DeMelo et al., 2006). The evaluation of alpha-glucosidase inhibitory ac-
tivity of B. saligna extracts revealed that the hexane fraction displayed
the highest activity (the lowest IC50 value). An IC50 value could not be
computed for the crude extract and dichloromethane fraction due to
Table 2
Anticholinesterase and alpha-glucosidase inhibitory properties of B. saligna crude extracts.
Sample AChE inhibition Alpha-glucosidase inhibition
IC50 (μg/ml) SI R2 value IC50 (mg/ml) SI R2 value
Crude extract 149.7 ± 21.34 a ND 0.9771 ND ND ND
Hexane fraction 124.8 ± 5.12 a 0.01 0.9796 0.26 ± 0.112 a 0.007 0.9698
Dichloromethane fraction 212.9 ± 5.87 b ND 0.9877 ND ND ND
Ethyl acetate fraction 140.7 ± 15.43 a ND 0.9748 0.58 ± 0.102 b ND 0.8206
Water fraction 206.4 ± 13.41 b ND 0.9901 2.02 ± 0.015 c ND 0.9444
Positive controls
Galanthamine (μg/ml) 0.22 ± 0.019 0.9767
Acarbose (mg/ml) 0.20 ± 0.015 0.9798
Mean values followed by different letters in the same column are signiﬁcantly different (P = 0.05) according to Duncan's multiple range Test. R2 is the coefﬁcient of determination for the
goodness of ﬁt of non-linear regression curve.
Selectivity index (SI) = IC50 CHO/IC50 (biological activity); ND = not determined.
8 J.C. Chukwujekwu et al. / South African Journal of Botany 94 (2014) 6–8the fact that an inhibitory activity less than 20% was observed at the
highest concentration tested (1.2 mg/ml). The IC50 value of the hexane
fraction (0.26 mg/ml) was comparable to that of the positive control
(0.20 mg/ml). Although this is very promising, the very low SI value of
this fraction with reference to alpha-glucosidase inhibition suggests
that it may be very toxic. It remains to be seen whether the toxicity ob-
served is caused by the compounds responsible for alpha-glucosidase
inhibition or other constituent phytochemical(s).
4. Conclusions
The present study demonstrated the antiplasmodial, anticholines-
terase and alpha-glucosidase inhibitory properties of B. saligna crude
extract and its fractions. On fractionation of the crude extract, the hex-
ane fraction stood out among all fractions with regards to the biological
activities determined. There was an improvement in biological activity
of the hexane fraction over the crude extract. However, the SI value of
this fraction in each biological activity investigated revealed that this
fraction may be toxic. This reinforces the importance of reporting the
SI values of biologically active samples togetherwith its biological activ-
ities. As fractions are mixtures of different constituents, which are not
known at this stage, future studies will help to unravel the constitu-
ent(s) and their biological activities. To the best of our knowledge, this
is the ﬁrst report of antiplasmodial, anticholinesterase and alpha-
glucosidase inhibitory properties of B. saligna. The safety of using this
plant species in traditional medicine for treating diabetes and mental-
related ailments must be carefully monitored.
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